Barclays ShareCast News (BARC)

Wednesday preview: Barclays delivers first-quarter results

Barclays will hog the spotlight Wednesday as it unveils its first-quarter results.
[23 Apr '13]

London close: Gains erased as US data disappoints

After a strong start, the FTSE 100 slumped into the red by the close on Monday afternoon as disappointing data and corporate earnings from the US dampened the positive mood.
[22 Apr '13]

FTSE 100 movers: Randgold Resources jumps higher

Randgold Resources was a strong riser - particularly compared to the rest of its sector - gaining after Blackrock upped its stake in the group to 14.1 per cent, marginally higher than the 14 per cent it previously owned.
[22 Apr '13]

Sector movers: Banks edge higher ahead of results season

Banking stocks were performing well on Monday, rebounding after bearing the brunt of falling risk appetite over the last week.
[22 Apr '13]

London midday: Banks provide a lift as markets shrug off UK downgrade

Markets were making decent gains on Monday morning, shrugging off the news that Fitch had stripped the UK of it prized 'AAA' credit rating, as investors went bargain hunting following some heavy falls the week before.
[22 Apr '13]

London open: Financials lead markets higher early on

Equities were making decent gains on Monday morning with financial stocks on the rise in London as markets attempted to claw their way back from heavy losses last week.
[22 Apr '13]

Friday newspaper round-up: Vodafone, Aviva, Vedanta...

"One of the biggest corporate deals in history edged closer yesterday after Verizon said that it was 'extremely confident' it could buy Vodafone's stake in North America's largest mobile network without triggering a huge tax bill," The Times says. Vodafone owns a 45 per cent stake in Verizon Wireless.
[19 Apr '13]

FTSE 100 movers: GSK rises on COPD treatment approval

Shares in pharmaceuticals giant GlaxoSmithKline gained after the the US FDA approved Breo Ellipta, the company's treatment for chronic obstructive pulmonary disease (COPD). "This positive recommendation is a crucial first step towards making Breo Ellipta available for appropriate COPD patients across the US," it said.
[18 Apr '13]